More than 1 million people in the U.S. live with psoriatic arthritis, or PsA. To educate the community about this chronic autoimmune disease, Celgene has partnered with the National Psoriasis Foundation (NPF) to launch the first-ever Psoriatic Arthritis Awareness Day on Wednesday, September 28th, 2016.
PsA Awareness Day is a day dedicated to raising awareness around the importance of recognition, diagnosis, and treatment. People are encouraged to join the movement at GoPsADay.com to learn factors associated with PsA, to help spread the word via their social channels, and to stand up and be counted for those living with this disease.
Psoriatic arthritis is a chronic inflammatory disease characterized by swelling, pain, and tenderness of the joints. It is also associated with the skin condition, psoriasis. In fact, in 85 percent of PsA patients, psoriasis occurs before joint disease.
It can be challenging living with this disease and can impact a person’s common day-to-day activities, such as walking up the stairs, driving a car, and doing laundry. While there is no cure, PsA can be managed. Early recognition, diagnosis, and treatment are critical to relieve the pain and inflammation of PsA. That is why it is important to know about some of the factors associated with PsA:
Those who are experiencing any of the common symptoms of PsA should contact their healthcare team.
To learn more about PsA and help spread the word about awareness day efforts, visit GoPsADay.com.